| Prediction of clinical pharmacokinetic parameters of linezolid using animal data by allometric scaling: applicability for the development of novel oxazolidinones. | |
| | |
MedLine Citation:
|
PMID: 15277016 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
1. Allometric scaling has previously been used as an effective tool for the prediction of human pharmacokinetic data. The pharmacokinetic data for linezolid, a novel oxazolidinone to treat Gram-positive pathogens, in mice, rats and dogs were subjected to simple allometric scaling. Generated allometric equations for parameters such as clearance (CL), volume of distribution (Vss) and elimination rate constant (K10) were used to predict human pharmacokinetic parameters including elimination half-lives. In addition, the human plasma concentration-time curve was simulated using a one-compartmental model. 2. Application of simple allometry (Y = aWb) for animal parameters such as CL, Vss, and K10 showed excellent allometric fit (r > or = 0.98). The allometric equations for CL, Vss, and K10 were -0.5465W(0.6595), -0.1369W(0.9246), and -0.4117W(-0.3139), respectively. The confidence in predictability of CL and Vss parameters was particularly high since the allometric exponents of CL and Vss almost approached the suggested values of 0.75 and 1.00, respectively. 3. Animal pharmacokinetic parameters generated in the present authors' laboratories for linezolid were in close agreement with reported literature values. The predicted human values for CL (4.68 l h(-1)), Vss (37.07 litres), and K10 (0.10 h(-1)) were within the range observed for linezolid in the literature (CL = 4-10.5 l h(-1); Vss = 21-53 litres; K10 = 0.09-0.3 h(-1)). The human half-life (t(1/2)) predicted using allometry (6.9 h) was similar to reported values in humans of 5 h. In summary, the retrospective analysis for linezolid suggests that allometric scaling can be used as a prospective tool for predicting human pharmacokinetic parameters of novel oxazolidinones. |
| | |
Authors:
|
R K Bhamidipati; P V Dravid; R Mullangi; N R Srinivas |
Related Documents
:
|
16945116 - Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysi... 11269566 - Dichloroacetate: population pharmacokinetics with a pharmacodynamic sequential link model. 18813046 - Population pharmacokinetic-pharmacodynamic modeling of epidural anesthesia. 12848776 - Physiologically based modelling of inhibition of metabolism and assessment of the relat... 22017826 - A bayesian assessment of the effect of highway bypasses in iowa on crashes and crash rate. 16199446 - Using factor analysis to evaluate checklist items. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Xenobiotica; the fate of foreign compounds in biological systems Volume: 34 ISSN: 0049-8254 ISO Abbreviation: Xenobiotica Publication Date: 2004 Jun |
Date Detail:
|
Created Date: 2004-07-27 Completed Date: 2005-10-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1306665 Medline TA: Xenobiotica Country: England |
Other Details:
|
Languages: eng Pagination: 571-9 Citation Subset: IM |
Affiliation:
|
Drug Metabolism and Pharmacokinetics, Discovery Research, Dr. Reddy's Laboratories Ltd, Miyapur, Hyderabad 500 049, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetamides
/
pharmacokinetics* Animals Body Size* Dogs Drug Design* Half-Life Humans Male Mice Models, Animal* Oxazolidinones / chemistry*, pharmacokinetics* Rats Rats, Wistar |
| Chemical | |
Reg. No./Substance:
|
0/Acetamides; 0/Oxazolidinones; 165800-03-3/linezolid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 s...
Next Document: Pharmacokinetics of two major hydroxylated polychlorinated biphenyl metabolites with specific retent...